1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 15 FEBRUARY 2016

World Generic Markets 15 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - FDA Budget Request Takes Aim At Pay-For-Delay Agreements
Industry Trend Analysis - Successful Integration And Restructuring Essential For Lannett's Future Prospects
Industry Brief - Vensun Launches Carisoprodol Tablets
Industry Brief - Aurobindo Gains Isosulfan Blue Approval
Industry Brief - Lupin Launches Metformin
Industry Trend Analysis - CMS Biosimilar Reimbursement Rule Highlights Need For Interchangeability Guidance
Industry Brief - Promius Pharma Gains Betamethasone Spray Approval
Industry Brief - Depomed Gains Favourable Markman Ruling In Tapentadol Litigation
Industry Trend Analysis - Pfizer Edges Towards US Biosimilar Infliximab Dominance
Industry Brief - Lannett Gains Temozolomide Approval
Industry Brief - FDA Approves Impax' Mixed Amphetamines ANDA
Industry Brief - EMA Accepts Sandoz' Biosimilar Pegfilgrastim Submission
Industry Brief - Biocon Gains EU Rosuvastatin Approval
Industry Brief - MedinCell/Sandoz Collaborate To Develop Long-Acting Injectable Products
Industry Trend Analysis - Meda Acquisition Will Expand Mylan's Product And Regional Outlook
Industry Brief - JHL Gains European Rituximab Trial Approval
Industry Trend Analysis - European Alimta Threats Will Place Further Pressure On Lilly
Industry Trend Analysis - Battle Against TPP Far From Over
Industry Trend Analysis - Generics Remain Essential For Teva As Copaxone Revenues Falter

Table Of Contents

World Generic Markets 15 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.